Phase II study on DON in patients with previously treated advanced lung cancer

MeSH terms

• Adenocarcinoma / drug therapy
• Aged
• Antibiotics, Antineoplastic / adverse effects
• Antibiotics, Antineoplastic / therapeutic use*
• Azo Compounds / therapeutic use*
• Carcinoma, Small Cell / drug therapy
• Carcinoma, Squamous Cell / drug therapy
• Diazooxonorleucine / adverse effects
• Diazooxonorleucine / therapeutic use*
• Drug Evaluation
• Female
• Humans
• Lung Neoplasms / drug therapy*
• Male
• Middle Aged
• Prognosis